WHOOP’S Series G round was led by Collaborative Fund and includes participation from 2PointZero Group, Qatar Investment Authority, Cristiano Ronaldo and LeBron James. The post WHOOP Secures $575M, Reaches $10B Valuation appeared first on MedCity News.
FDA approval for Eli Lilly’s oral GLP-1 drug, Foundayo, comes about three months after Novo Nordisk launched its Wegovy pill. While clinical trial results for both daily pills showed comparable weight reduction, Lilly’s pill offers patients a slight dosing advantage. The post Eli Lilly Gets Speedy FDA Nod for Oral GLP-1 Drug, a Competitor to…
Untreated dental problems are driving millions of Americans to emergency rooms each year, costing the country billions and worsening chronic health conditions. Experts say bridging the historic divide between medical and dental care — through data connectivity, integrated health centers and AI-driven tools — could improve patient outcomes and reduce healthcare spending. The post From…
Legacy payers have had decades to readjust their approach. Costs continue to climb, patients still face denials, and physicians remain mired in bureaucracy. It’s time to replace a system built on restrictions with one built on trust — trust in clinicians to practice medicine and in patients to make informed choices. The post Fixing Healthcare…
The future of surgery will be shaped less by what our tools can do than by how well our systems help humans think when it matters most. The question is no longer whether the OR will evolve. It’s who will lead the transition The post The Digital Imperative: Why the Future of Surgery Will Be…
March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Flare Capital Partners, SCAN Group and Advocate Health named new executives. There were also layoffs at organizations including Oracle, Takeda and Blue Shield of California. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared…
Jimini’s $17 million round was from M13, Town Hall Ventures, LionBird, Zetta Venture Partners and OneMind. The post Jimini Health Raises $17M to Scale Clinician-Supervised AI for Behavioral Health appeared first on MedCity News.
Centessa Pharmaceuticals’ cleminorexton is part of the orexin agonist drug class, which could introduce a new approach to the treatment of narcolepsy and other sleep disorders. Acquiring Centessa brings Eli Lilly into a group of clinical-stage orexin agonist drug developers that includes Takeda Pharmaceutical, Alkermes, and Eisai. The post Eli Lilly’s Neuro Prospects Expand to…
By Andy Petrovich, National Vice President, Crothall Healthcare & Afif Eschiek, National Director, Crothall Healthcare Many sterile processing departments manage thousands of reusable devices from thousands of manufacturers, each with its unique reprocessing requirements. Hospitals rely on clear instructions for use (IFUs) to safely reprocess these medical devices. Yet inconsistent or impractical instructions continue to…
Whether AI-driven or legacy applications, the endpoint is the decisive moment. As AI increases in use, having hardware and software that supports a high-performance experience for all staff will improve operational efficiency, patient outcomes, and revenue. The post Healthcare Staff can Maximize the Value of AI with High Performing Endpoints appeared first on MedCity News.